UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:November 14,
Kodiak Sciences (NASDAQ:KOD)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Kodiak Sciences Charts.
Kodiak Sciences (NASDAQ:KOD)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Kodiak Sciences Charts.

Kodiak Sciences Inc. News

Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Thursday 28 March 2024 (1 month ago) • PR Newswire (US)
Kodiak Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results and Host Business Updates Webcast on March 28, 2024
Tuesday 26 March 2024 (1 month ago) • PR Newswire (US)
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Thursday 15 February 2024 (3 months ago) • Edgar (US Regulatory)
Kodiak Sciences Announces Upcoming Presentation of First Time Results of KSI-501ABC Phase 1 Study at the Angiogenesis, Exudation, and Degeneration 2024 Virtual Meeting
Tuesday 30 January 2024 (3 months ago) • PR Newswire (US)
Kodiak Sciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Friday 5 January 2024 (4 months ago) • PR Newswire (US)
Kodiak Sciences to Present at the 6th Annual Evercore ISI HealthCONx Conference
Wednesday 22 November 2023 (5 months ago) • PR Newswire (US)
Kodiak Sciences Announces Third Quarter 2023 Financial Results and Recent Business Highlights
Wednesday 15 November 2023 (6 months ago) • PR Newswire (US)
Form 8-K - Current report
Monday 6 November 2023 (6 months ago) • Edgar (US Regulatory)
Kodiak reboots tarcocimab tedromer development program following strong positive results in Phase 3 diabetic retinopathy GLOW study and following dialogue with US regulatory authorities on a regulatory pathway for BLA submission
Monday 6 November 2023 (6 months ago) • PR Newswire (US)
KODIAK SCIENCES ANNOUNCES FIRST TIME PRESENTATION OF PRIMARY ENDPOINT DATA FROM TARCOCIMAB TEDROMER PHASE 3 GLOW STUDY IN PATIENTS WITH DIABETIC RETINOPATHY AT AMERICAN ACADEMY OF OPHTHALMOLOGY ANNUAL MEETING
Thursday 2 November 2023 (6 months ago) • PR Newswire (US)
Kodiak Sciences Announces Upcoming Presentations at the 56th Annual Scientific Meeting of the Retina Society
Wednesday 11 October 2023 (7 months ago) • PR Newswire (US)
Kodiak Sciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
Friday 8 September 2023 (8 months ago) • PR Newswire (US)

More Kodiak Sciences Inc. News Articles